X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tnf-targeted therapies (10) 10
adalimumab (7) 7
humans (7) 7
rheumatology (7) 7
female (6) 6
index medicus (6) 6
infliximab (5) 5
risk factors (5) 5
aged (4) 4
male (4) 4
middle aged (4) 4
agents (3) 3
antirheumatic agents - therapeutic use (3) 3
disease (3) 3
etanercept (3) 3
abridged index medicus (2) 2
adult (2) 2
animals (2) 2
anti-inflammatory agents - adverse effects (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
antirheumatic agents - adverse effects (2) 2
arthritis, rheumatoid - drug therapy (2) 2
autoimmune-diseases (2) 2
biological products - adverse effects (2) 2
dermatology (2) 2
diagnosis (2) 2
erythematosus (2) 2
immunologic factors - therapeutic use (2) 2
lupus (2) 2
mortality (2) 2
necrosis-factor-alpha (2) 2
retrospective studies (2) 2
rheumatoid arthritis (2) 2
rheumatoid-arthritis (2) 2
safety (2) 2
systemic lupus erythematosus (2) 2
tuberculosis (2) 2
tumor necrosis factor-alpha - antagonists & inhibitors (2) 2
young adult (2) 2
abdominal pain - chemically induced (1) 1
adolescent (1) 1
adrenal cortex hormones - therapeutic use (1) 1
adverse reactions (1) 1
aged, 80 and over (1) 1
allergy (1) 1
alopecia areata (1) 1
alpha (1) 1
alpha antagonist etanercept (1) 1
analysis (1) 1
anti-histone antibodies (1) 1
anti-tnf (1) 1
anti-tnf alpha (1) 1
anti-tnf therapy (1) 1
anti-tnfα (1) 1
anti-tumour necrosis factor-alpha (1) 1
anti-tumour necrosis factor-α (1) 1
antibodies (1) 1
antibodies, monoclonal, humanized (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antibodies, monoclonal, murine-derived - therapeutic use (1) 1
antineoplastic agents - administration & dosage (1) 1
antinuclear antibodies (1) 1
antirheumatic agents (1) 1
anti‐tnfα (1) 1
apoptosis - drug effects (1) 1
apoptosis - physiology (1) 1
arthralgia - complications (1) 1
arthritis, rheumatoid - complications (1) 1
arthritis, rheumatoid - mortality (1) 1
assays (1) 1
atopic-dermatitis (1) 1
autoimmune (1) 1
autoimmune diseases - drug therapy (1) 1
autoimmunity (1) 1
autoimmunity - drug effects (1) 1
azathioprine - therapeutic use (1) 1
biologic agents (1) 1
biological products - therapeutic use (1) 1
biological therapy (1) 1
biologics (1) 1
biopsy (1) 1
care and treatment (1) 1
case studies (1) 1
case-control studies (1) 1
cell biology (1) 1
clinical science (1) 1
cohort studies (1) 1
cohort study (1) 1
colitis, ulcerative - drug therapy (1) 1
control (1) 1
controlled trial (1) 1
crohn disease - complications (1) 1
crohn disease - drug therapy (1) 1
crohns-disease (1) 1
cyclophosphamide - administration & dosage (1) 1
cyclophosphamide - therapeutic use (1) 1
cyclosporine (1) 1
cyclosporine - therapeutic use (1) 1
dermatomyositis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 2015, Volume 45, Issue 4, pp. 391 - 399
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2012, Volume 87, Issue 8, pp. 739 - 745
Journal Article
Postepy Dermatologii i Alergologii, ISSN 1642-395X, 06/2018, Volume 35, Issue 3, pp. 323 - 324
...: 27.03.2017. A case of leukocytoclastic vasculitis associated with anti-tumor necrosis factor therapy Dorota Sikorska1, Renata Marcinkowska-Pięta1, Ewa Mojs1, Ryszard... 
ADALIMUMAB | ALLERGY | DISEASE | ALPHA | AGENTS | TNF-TARGETED THERAPIES | PSORIASIS | DERMATOLOGY | Letter to the Editor
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 04/2011, Volume 25, Issue 4, pp. 479 - 484
...  The objective of the study is to characterize AA developed during anti‐TNF‐α therapy. Methods  We present five new cases and review all the cases reported in the literature... 
anti‐TNFα | autoimmune | alopecia areata | etanercept | infliximab | adalimumab | anti-TNFα | RHEUMATOID-ARTHRITIS | UNIVERSALIS | BIOLOGIC AGENTS | anti-TNF alpha | TNF-TARGETED THERAPIES | DERMATOLOGY
Journal Article
Journal Article
TURKISH JOURNAL OF RHEUMATOLOGY, ISSN 1309-0291, 12/2011, Volume 26, Issue 4, pp. 328 - 332
... to strongly positive. Her creatinine kinase levels remained normal. She responded well to high-dose steroid therapy and rituximab. 
ANTIBODIES | DERMATOMYOSITIS | NECROSIS-FACTOR-ALPHA | RHEUMATOLOGY | TNF-TARGETED THERAPIES | ERYTHEMATOSUS | anti-TNF therapy | DISEASE | drug-induced lupus erythematosus | Adalimumab | INFLIXIMAB | INHIBITOR | lupus myositis
Journal Article
2005 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005 Technical Proceedings, 2005, pp. 7 - 10
Conference Proceeding
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.